Literature DB >> 23744864

Non-small cell lung cancer, version 2.2013.

David S Ettinger1, Wallace Akerley, Hossein Borghaei, Andrew C Chang, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy, Ramaswamy Govindan, Frederic W Grannis, Stefan C Grant, Leora Horn, Thierry M Jahan, Ritsuko Komaki, Feng-Ming Spring Kong, Mark G Kris, Lee M Krug, Rudy P Lackner, Inga T Lennes, Billy W Loo, Renato Martins, Gregory A Otterson, Jyoti D Patel, Mary C Pinder-Schenck, Katherine M Pisters, Karen Reckamp, Gregory J Riely, Eric Rohren, Theresa A Shapiro, Scott J Swanson, Kurt Tauer, Douglas E Wood, Stephen C Yang, Kristina Gregory, Miranda Hughes.   

Abstract

These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer. The NCCN Guidelines Insights focus on the major updates in the NCCN Guidelines and discuss the new updates in greater detail.

Entities:  

Mesh:

Year:  2013        PMID: 23744864     DOI: 10.6004/jnccn.2013.0084

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  181 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups.

Authors:  Xiaofei Wang; Lin Gu; Ying Zhang; Daniel J Sargent; William Richards; Apar Kishor Ganti; Jeffery Crawford; Harvey Jay Cohen; Thomas Stinchcombe; Everett Vokes; Herbert Pang
Journal:  Lung Cancer       Date:  2015-08-18       Impact factor: 5.705

3.  Coincident detection of lung metastasis of prostate cancer and primary lung cancer: A case report.

Authors:  Yusuke Muro; Takeo Kosaka; Tai Hato; Shuji Mikami; Mototsugu Oya
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

4.  BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.

Authors:  J Wang; Y Jia; S Zhao; X Zhang; X Wang; X Han; Y Wang; M Ma; J Shi; L Liu
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

5.  Is there clinical value to prognostic signatures in early-stage NSCLC?

Authors:  Paul A Bunn; Fred R Hirsch; Dara L Aisner
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

Review 6.  Lung stem and progenitor cells in tissue homeostasis and disease.

Authors:  Kristen T Leeman; Christine M Fillmore; Carla F Kim
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

7.  Prognostic significance of histologic subtype in pStage I lung adenocarcinoma.

Authors:  Nozomu Motono; Takuma Matsui; Yuichiro Machida; Katsuo Usuda; Hidetaka Uramoto
Journal:  Med Oncol       Date:  2017-04-21       Impact factor: 3.064

8.  Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.

Authors:  Xiaobin Gu; Tian Tian; Bo Zhang; Yang Liu; Chao Yuan; Lijuan Shao; Yajun Guo; Kexing Fan
Journal:  Tumour Biol       Date:  2014-12-06

9.  TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Stephen Safe
Journal:  Mol Cancer Res       Date:  2018-08-02       Impact factor: 5.852

Review 10.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.